Market Signal Briefing

VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, today confirmed the closing of its Credit Agreements with Community Savings Credit Union (“CSCU”). The Company has received $3,000,000 from the Capital Loan and now has access to a $1,000,000 Line of Credit, as outlined in its November 10, 2025 news release.

The Credit Agreements, secured against the Cascadia Facility, will be used by the Company to fund margin accretive projects at its Pacifica and Cascadia Facilities.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.

The Company’s production base is anchored by its Pacifica facility (Delta, BC) and is now complemented by the acquisition and licensing of its Cascadia facility (Hope, BC), which will expand production capacity by over 40% and support future growth in both domestic and export markets. With proprietary genetics, award-winning products, and certifications enabling international distribution, Rubicon is positioned at the forefront of the premium cannabis segment.

As the Canadian market continues to rationalize and global demand for high-quality cannabis increases, Rubicon Organics’ disciplined execution, brand equity, and consumer loyalty set it apart. The Company’s focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA.

Rubicon Organics represents a rare combination of category leadership, operational strength, and long-term growth potential.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: [email protected]

The TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws, including, but not limited to, statements regarding the use of proceeds from the Credit Agreements, and expected projects at the Pacifica and Cascadia Facilities. Forward-looking information is based on management’s current expectations and assumptions, which are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements.

Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, but are not limited to, general economic conditions, changes in regulatory requirements, operational risks, market demand, competition, and other risk factors set forth in the Company’s public filings available on SEDAR+ at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on such forward-looking information. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

All forward-looking information in this press release is made as of the date hereof and is based on the beliefs, estimates, and opinions of management as of the date such statements are made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable law.

December 02, 2025 9:13 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 30, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements, as well as failed to disclose material adverse facts about Synopsys' business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) the extent to which Synopsys' increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, "certain road map and resource decisions" were unlikely to "yield their intended results,"; (3) that the foregoing had a material negative impact on financial results; and (4) as a result of the foregoing, defendants' positive statements about Synopsys' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276750

December 02, 2025 9:18 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Western Alliance Bancorporation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=46349 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On October 16, 2025, Western Alliance Bancorporation disclosed that it had initiated a lawsuit against a borrower, Cantor Group V LLC, alleging fraud related to collateral loans.

On this news, Western Alliance Bancorporation's stock fell 10.88% on October 16, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276753

December 02, 2025 7:30 PM EST | Source: Powermax Minerals Inc.
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) ("Powermax" or the "Company") wishes to announce a board change, effective immediately, Michael Nederhoff will join the board of directors replacing the Michael Malana. The Company wishes to thank Mr. Malana for his service.

Michael Nederhoff has a diverse work experience spanning several industries. Michael is the Chief Operating Officer at Served With Honor. Prior to that, he ran his own independent agency called WiLRo Consulting, which specialized in strategy, sales, marketing, distribution, brand management, and new product development. Michael has worked with various clients, including Jagermeister, Dry Soda, Mindset, Waisamama, Sesh+, and several start-ups. Nederhoff also worked as an Executive in Residence at Co.Labs and as the Chairman of the Board at Psyched Wellness. Before that, he was the CEO of Shelter and the President of JUUL Labs. His earlier experiences include serving as the General Manager at CytoSport, Inc., the VP of Sales at Red Bull Canada, the Director of Sales at Frito Lay, and holding various roles at Cadburys Schweppes PLC as the Director of Sales/Regional Manager/BDM/NAM.

In conjunction with Michael joining the board of directors of Powermax Minerals, 200,000 stock options and 300,000 restricted stock units ("RSU") will be granted.

"Michael Nederhoff joining the board adds synergies and efficiencies to Powermax," commented Paul Gorman, CEO of Powermax. "We thank Michael Malana for his efforts and continued support of the company."

The Company is also pleased to announce that it has renewed its agreement with Euro Digital Media Ltd. ("Euro Digital") ​(address: 71-75 Shelton Street, Covent Garden, London, UK. WC2H 9JQ; ​email: [email protected]) for marketing services for up to an additional three months commencing on or about December 4th, 2025​, or until budget exhaustion, and that the term of the marketing services may be extended or shortened at the discretion of management depending on, amongst other things, the efficacy of the marketing services.

Euro Digital shall, as appropriate, create campaigns, ad groups, text ads, display ads, perform detailed keyword research, setup and manage remarketing campaigns, optimize keyword options, coordinate online advertisers and marketers corresponding to online marketing targets, create landing pages for ad campaigns and generally bring attention to the business of the Company. The promotional activity undertaken by Euro Digital will occur on a www.thestockreport.com landing page, and via Google ads and native advertising.

The Company will pay a fee of USD $500,000 (plus GST) to Euro Digital. The Company will not issue any securities to Euro Digital as compensation for its marketing services. As of the date hereof, to the Company's knowledge, Euro Digital (including its directors and officers) does not own any securities of the Company and has an arm's length relationship with the Company.

About Powermax Minerals Inc.

Powermax Minerals Inc. is a Canadian mineral exploration company focused on advancing rare earth element projects. The Company holds an option to acquire the Cameron REE Property, comprising three mineral claims totaling approximately 2,984 hectares in British Columbia. Powermax also optioned to acquire the Atikokan REE Property, consisting of 455 unpatented mining claims in NW Ontario. Powermax also owns a 100% interest in the Ogden Bear Lodge Project, in Crook County, Wyoming.

Forward-Looking Statements

All statements included in this press release that address activities, events or developments that Powermax expects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements may involve, but are not limited to, statements with respect to the exploration and development of the Company's mineral properties and the granting of stock options and restricted stock units. These forward-looking statements involve numerous assumptions made by Powermax based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will prove inaccurate, certain of which are beyond Powermax's control. Readers should not place undue reliance on forward-looking statements. Except as required by law, Powermax does not intend to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

Neither the Canadian Securities Exchange nor its Regulation Service Provider accepts responsibility for the adequacy or accuracy of this news release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276732

Pure Storage (PSTG - Free Report) reported $964.45 million in revenue for the quarter ended October 2025, representing a year-over-year increase of 16.1%. EPS of $0.58 for the same period compares to $0.50 a year ago.

The reported revenue represents a surprise of +0.66% over the Zacks Consensus Estimate of $958.14 million. With the consensus EPS estimate being $0.59, the EPS surprise was -1.69%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Pure Storage performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Subscription Annual Recurring Revenue (ARR): $1.8 billion compared to the $1.88 billion average estimate based on two analysts.Remaining Performance Obligations (RPO): $2.9 billion compared to the $2.82 billion average estimate based on two analysts.Revenue- Product: $534.76 million compared to the $510.23 million average estimate based on nine analysts. The reported number represents a change of +17.6% year over year.Revenue- Subscription services: $429.69 million compared to the $447.07 million average estimate based on nine analysts. The reported number represents a change of +14.2% year over year.Non-GAAP Gross profit- Subscription services: $324.53 million versus the nine-analyst average estimate of $342.56 million.Non-GAAP Gross profit- Product: $389.7 million versus the nine-analyst average estimate of $343.76 million.View all Key Company Metrics for Pure Storage here>>>

Shares of Pure Storage have returned -10.2% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

For the quarter ended October 2025, MongoDB (MDB - Free Report) reported revenue of $628.31 million, up 18.7% over the same period last year. EPS came in at $1.32, compared to $1.16 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $591.22 million, representing a surprise of +6.27%. The company delivered an EPS surprise of +67.09%, with the consensus EPS estimate being $0.79.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how MongoDB performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

MongoDB Atlas customers: 60,800 versus the three-analyst average estimate of 59,906.Revenue- Services: $19.24 million compared to the $18.3 million average estimate based on eight analysts. The reported number represents a change of +12.1% year over year.Revenue- Subscription: $609.07 million compared to the $572.95 million average estimate based on eight analysts. The reported number represents a change of +18.9% year over year.Revenue- Subscription - MongoDB Atlas-related: $470.4 million versus the three-analyst average estimate of $455.82 million. The reported number represents a year-over-year change of +29.7%.Revenue- Subscription - Other subscription: $138.67 million compared to the $114.85 million average estimate based on three analysts. The reported number represents a change of -7.3% year over year.View all Key Company Metrics for MongoDB here>>>

Shares of MongoDB have returned -10.9% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.

December 02, 2025 7:40 PM EST | Source: Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their Options

If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - December 2, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX) and reminds investors of the January 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) Defendants materials overstated the quality of Telix's supply chain and partners; and (3) as a result, defendants statements about Telix's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On July 22, 2025, Telix Pharmaceuticals revealed that it "received a subpoena from the U.S. Securities and Exchange Commission . . . seeking various documents and information primarily relating to the Company's disclosures regarding the development of the Company's prostate cancer therapeutics candidates."

On this news, the price of Telix Pharmaceuticals American Depositary Shares ("ADSs") fell more than 13% over two trading sessions, according to the complaint.

Then, on August 28, 2025, the complaint further alleges that Telix Pharmaceuticals disclosed that it received a Complete Response Letter from the U.S. Food and Drug Administration ("FDA") for the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will require remediation prior to resubmission."

The Telix Pharmaceuticals class action lawsuit alleges that on this news, the price of Telix Pharmaceuticals ADSs fell more than 21% over two trading sessions.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Telix's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Telix Pharmaceuticals class action, go to www.faruqilaw.com/TLX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276495

A competitor recently earned FDA approval, but this drug is reportedly going to be pricey.

An analyst's very bullish new research note was the spark that lit a fire under the stock of Vera Therapeutics (VERA +12.88%) on Tuesday. That extremely positive investor reaction boosted the share price of the clinical-stage biotech by almost 13% on the day.

Price advantage?
The analyst in question was Ryan Deschner of Raymond James, who reiterated his strong buy recommendation on Vera stock. He also maintained his $73 per share price target on the healthcare company.

Image source: Getty Images.

According to reports, Deschner's update centered on its leading pipeline drug atacicept. This is a therapy being developed to treat the kidney disorder IgA nephropathy (IgAN), also known as Berger's disease.

The analyst noted that a potential competitor recently approved by the Food and Drug Administration (FDA), Otsuka Pharmaceutical's Voyxact, has been priced by its developer at $30,000 per once-ever-four-week treatment. That's around double what Deschner believes atacicept's cost will be.

Today's Change

(

12.88

%) $

4.25

Current Price

$

37.25

Competitive right out of the gate
If Deschner's price assumption is correct, or even somewhat in the ballpark, Vera would have a clear advantage when and if its treatment does well in clinical trials and is ultimately approved by regulators.

As ever in the biotech world, of course, the "ifs" matter. So far, though, atacicept's development has generally progressed well, so I'd imagine it has at least a decent chance of reaching pharmacy shelves.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Marvell Technology, Inc. (MRVL) Q3 2026 Earnings Call Transcript

Descartes’ steady financial results weren’t enough to keep one major investor from cutting back—here’s what the move signals.

New York City-based Praesidium Investment Management Company cut its stake in The Descartes Systems Group (DSGX +0.67%) by 206,057 shares in the third quarter, according to a November 14 SEC filing.

What HappenedPraesidium Investment Management Company reported in a U.S. Securities and Exchange Commission (SEC) filing dated November 14 that it reduced its holdings in The Descartes Systems Group (DSGX +0.67%) by 206,057 shares in the third quarter. The estimated net decrease in position value was $22.8 million, bringing the fund’s stake to 251,840 shares valued at $23.7 million as of September 30.

What Else to KnowThe fund’s DSGX holding now represents 4.6% of 13F assets, down from 8.2% in the previous quarter.

Top five holdings after the filing: 

NYSE: JBL: $75.8 million (14.8% of AUM)NASDAQ: INTA: $71.3 million (13.9% of AUM)NASDAQ: FROG: $70.8 million (13.8% of AUM)NYSE: NOW: $61.9 million (12.1% of AUM)NASDAQ: ALKT: $50.1 million (9.8% of AUM)As of Tuesday, DSGX shares were priced at $83.36, down 29% over the past year and well underperforming the S&P 500, which is up 13% in the same period.

Company OverviewMetricValueMarket Capitalization$7.1 billionRevenue (TTM)$684.8 millionNet Income (TTM)$148.2 millionPrice (as of market close Tuesday)$82.51Company SnapshotThe Descartes Systems Group offers cloud-based logistics and supply chain management solutions, including routing, transportation management, customs compliance, and e-commerce warehouse management.The company operates a modular, software-as-a-service (SaaS) platform.It serves transportation providers, logistics service providers, manufacturers, retailers, distributors, and mobile business service providers globally.The Descartes Systems Group is a leading provider of cloud-based logistics and supply chain management software, enabling organizations to optimize delivery, compliance, and trade processes across complex global networks. The company leverages a scalable SaaS model, delivering mission-critical solutions that support operational efficiency and regulatory compliance for logistics-intensive businesses. Its broad customer base and integrated platform position it as a key technology partner in the global logistics ecosystem.

Foolish TakePraesidium’s latest move seems like it could be a recalibration rather than a retreat. The Descartes Systems Group has continued to post steady revenue and earnings growth, but the fund’s reduced exposure suggests that even consistent operators aren’t immune when portfolio priorities shift—especially after a year in which the stock has badly lagged broader markets. For context, Descartes grew Q2 revenue 10% year over year to $179.8 million, with net income rising 10% to $38 million and operating cash flow jumping 82% to $63.3 million, according to its latest quarterly report.

Still, even solid fundamentals couldn’t offset broader uncertainty around the global trade environment. With shares down 29% over the past year, Descartes has meaningfully underperformed Praesidium’s other top holdings, several of which skew toward higher-growth or more event-driven names. The trimming brings DSGX down to 4.6% of reportable assets—nearly halving its weight from the prior quarter.

For long-term investors, the takeaway is twofold: Descartes remains financially resilient, but sentiment-driven volatility can overshadow fundamentals. Continued margin strength and strong cash generation could provide a stabilizing floor, yet the stock’s muted trajectory means patience is key.

Glossary13F reportable assets: Assets that institutional investment managers must report quarterly to the SEC on Form 13F.
AUM (Assets Under Management): The total market value of assets that an investment firm manages on behalf of clients.
Top five holdings: The five largest investments in a fund's portfolio, usually by market value or percentage of assets.
Position: The amount of a particular security or investment held by an investor or fund.
Modular platform: Software architecture allowing users to select and combine different functional components based on their needs.
Software-as-a-Service (SaaS): A software delivery model where applications are hosted remotely and accessed via the internet, typically by subscription.
Logistics service providers: Companies that manage the movement, storage, and flow of goods for other businesses.
Customs compliance: Adhering to laws and regulations governing the import and export of goods across international borders.
Mission-critical: Essential systems or processes whose failure would seriously impact business operations.
Integrated platform: A system combining multiple tools or services into a unified solution for users.
Regulatory compliance: Following all laws, rules, and regulations relevant to business operations.
TTM: The 12-month period ending with the most recent quarterly report.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Descartes Systems Group, Intapp, and ServiceNow. The Motley Fool recommends JFrog. The Motley Fool has a disclosure policy.

NEW YORK--(BUSINESS WIRE)---- $AVTR #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE:AVTR) securities during the period of March 5, 2024 through October 28, 2025, inclusive (“the Class Period”). If you suffered a loss on your Avantor investments, you have until December 29, 2025 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS].

MobED, Hyundai Motor Group Robotics LAB's first mass-produced mobility robot platform, is designed for diverse industrial and everyday applications
MobED debuts an innovative approach to robotics functionality, defined by Adaptive Mobility (H/W), Intuitive Autonomy (S/W) and Infinite Journey (applications)
MobED features AI-based autonomous navigation, LiDAR-camera fusion sensors, and an eccentric posture control mechanism for stable and adaptive movement
Design blends precision and elegance, with integrated sensors and Drive-and-Lift (DnL) modules ensuring exceptional balance and optimized functionality
MobED Pro and MobED Basic models scheduled for sales in the first half of 2026; both units demonstrated at the Group's iREX booth
Technical seminar and MobED capability showcase at the Group's iREX 2025 booth (West Hall 3-4, W3-44) from December 3 to 6
, /PRNewswire/ -- Hyundai Motor Group (the Group) today unveiled MobED (Mobile Eccentric Droid), its first mass-produced mobility robot platform developed by Hyundai Motor Group's Robotics LAB, at the International Robot Exhibition 2025 (iREX 2025) in Tokyo, Japan.

Hyundai Motor Group Unveils Production-Ready Autonomous Mobility Robot Platform ‘MobED’ at iREX 2025

First shown as a concept robot at Consumer Electronics Show (CES) 2022, MobED has been refined into a production-ready, fully autonomous mobility robot platform using artificial intelligence (AI). The new model takes center stage at the Group's iREX 2025 booth (West Hall 3-4, W3-44), running from December 3 to 6. Promotional videos showcasing MobED are also accessible via the Group's official YouTube channel. Watch the video here.

"Beyond a simple mobility platform, MobED offers a next-generation solution adaptable to diverse industries and everyday life. MobED will set new standards in the global robotics market and accelerate a future where humans and robots coexist." – Dong Jin Hyun, Vice President and Head of Hyundai Motor Group Robotics LAB.

What are MobED's Key Product Features?

MobED introduces a groundbreaking approach to robotics functionality, defined by three pillars: Adaptive Mobility (hardware), Intuitive Autonomy (software) and Infinite Journey (applications).

More information about Hyundai Motor Group can be found at: http://www.hyundaimotorgroup.com or Newsroom: Media Hub by Hyundai, Kia Global Media Center (kianewscenter.com), Genesis Newsroom

SOURCE Hyundai Motor Group

Q2: 2025-11-25 Earnings SummaryEPS of $2.05 beats by $0.17

 |

Revenue of

$1.71B

(2.83% Y/Y)

beats by $18.89M

NetApp, Inc. (NTAP) UBS Global Technology and AI Conference 2025 December 2, 2025 5:35 PM EST

Company Participants

Kris Newton - VP of Corporate Communications & Investor Relations
George Kurian - CEO & Director

Conference Call Participants

David Vogt - UBS Investment Bank, Research Division

Presentation

David Vogt
UBS Investment Bank, Research Division

Great. Good afternoon, everyone. Thank you again for joining the UBS Tech Conference. I'm David Vogt. I'm one of the tech analysts here at UBS. And we're excited to have George Kurian from NetApp here, Chief Executive Officer. Before we kick off, Kris has a disclaimer she needs to read for all of us.

Kris Newton
VP of Corporate Communications & Investor Relations

Very important information. Today's discussion may include forward-looking statements regarding NetApp's future performance, which are subject to risks and uncertainty. Actual results may differ materially from statements made today for a variety of reasons as described in our most recent 10-K and 10-Q filed with the SEC and available on our website at netapp.com. We disclaim any obligation to update information in any forward-looking statement for any reason. Back to you, David.

David Vogt
UBS Investment Bank, Research Division

Thanks, Kris. Thanks again, George, for coming.

George Kurian
CEO & Director

Thank you for having me. Thank you for coming.

Question-and-Answer Session

David Vogt
UBS Investment Bank, Research Division

So we just came off of earnings last week. So I think this is incredibly timely. What I thought we should do is maybe start with kind of just a quick overview of what you saw last quarter. Results were stronger, gross margin strong despite, I think, people's fear about commodity prices, other competitive issues. So maybe we can start there and talk about kind of what you saw in the quarter and how we're thinking about the January quarter and beyond through your fiscal year.

Recommended For You

ALVO Investors with Losses Encouraged to Contact the Firm

, /PRNewswire/ -- Shareholder rights firm Hagens Berman is scrutinizing Icelandic biopharmaceutical company Alvotech (NASDAQ: ALVO) over the propriety of its disclosures regarding its lead drug candidate and its manufacturing operations, following a dramatic revision to the company's full-year financial forecasts.

The firm urges investors in Alvotech who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Visit: www.hbsslaw.com/investor-fraud/alvo
Contact the Firm Now: [email protected]
                                       844-916-0895

Alvotech (ALVO) Investigation:

The central focus of the inquiry revolves around whether Alvotech provided adequate transparency to the market concerning the status of its Biologics License Application (BLA) for AVT05—a critical biosimilar product—and the underlying manufacturing practices at its flagship Reykjavik facility. The assumptions related to these practices were "baked into" the company's ambitious 2025 revenue projections.

On May 8, 2025, Alvotech increased its full year revenue guidance for 2025 to $600-$700 million and full year adjusted EBITDA to $200-$280 million.

Three months later, on August 14, 2025, the company reiterated these robust forecasts. Furthermore, in its earnings commentary, management touted its pending marketing application for AVT05 in "major global markets," asserting this momentum would make "the fourth quarter… by far the strongest one of this year."

The narrative of steady growth was abruptly shattered on November 2, 2025, when Alvotech shocked investors when it announced the FDA issued a CRL that disclosed that "[t]e CRL noted that certain deficiencies, which were conveyed following the FDA's pre-license inspection of Alvotech's Reykjavik manufacturing facility that concluded in July 2025, must be satisfactorily resolved before this BLA for ATV05 can be approved."

The company reduced its 2025 revenue to $570-$600 million and adjusted EBITDA to just $130-$150 million, respectively. These reductions were critical to investors because they amounted to lowered forecasted revenue range by about 10% below the prior midpoint and a whopping lowered adjusted EBITDA range by about 58% from the prior midpoint.

As to the latter, Alvotech stated it was "primarily driven by expected continuation of investments related to resolving certain facility issues, which also require a temporary slowdown in production."

The news sent Alvotech shares crashing about 33% on November 3, 2025, wiping out hundreds of millions of dollars in market value in a single day.

"We're focused on investors' losses and whether Alvotech may have misled investors about its interactions with the FDA and the commercial prospects of ATV05," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in Alvotech and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »

If you'd like more information and answers to frequently asked questions about the Alvotech investigation, read more »

Whistleblowers: Persons with non-public information regarding Alvotech should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

SOURCE Hagens Berman Sobol Shapiro LLP

Verra Mobility Corporation (VRRM) Presents at UBS Global Technology and AI Conference 2025 Transcript

Bitcoin's ascent has been impressive, and it may be far from over.

Bitcoin (BTC +5.96%) is once again on the move today, with the world's largest cryptocurrency skyrocketing off its low of around $85,000 yesterday to above $91,000 at the time of writing. Over the past 24 hours, this impressive 6% move (as of 5 p.m. ET) has added nearly $140 billion in market capitalization to this token and improved the balance sheets of many Bitcoin treasury companies, crypto miners, and institutional funds that rely on Bitcoin's price heading higher.

Today's Change

(

5.96

%) $

5138.37

Current Price

$

91398.00

Indeed, given Bitcoin's pivotal role in the broader digital assets sector, this is a significant move that warrants further exploration. Let's try to unravel some of the reasons behind this move. Here are the top three catalysts I'm currently monitoring.

3 key catalysts driving Bitcoin's move today

Source: Getty Images.

Perhaps the most notable catalyst I've seen espoused as the primary driver of today's move in Bitcoin is the broadly improving sentiment among market participants, whether in the crypto market or in other high-growth asset classes. Tech stocks rebounded nicely today, the 10-year Treasury rallied, and the overall market capitalization of all cryptocurrencies surged by more than 5% over the same 24-hour period noted above.

The reality is that sentiment and macroeconomic developments play a larger role in Bitcoin's daily price moves than is the case with other cryptocurrencies. That's due in large part to this top token's size and importance to a host of other Bitcoin treasury companies, miners, and institutional investors (or those in spot ETFs), which can push or pull capital toward Bitcoin in meaningful ways every day.

That said, the second key catalyst I think is even more pertinent for Bitcoin today is liquidation data around perpetual futures contracts. These derivatives allow investors to place leveraged bets on directional moves in the price of Bitcoin over short periods of time. With the market turning increasingly bearish, a reversal of sentiment has led to the liquidation of more than $165 million worth of short derivatives contracts over the past day. What that means in plain speak is that those looking to short Bitcoin (or benefit from a continued downside move) have been wiped out, allowing for an even more violent upswing in this cryptocurrency's price.

Finally, solid data on net inflows into spot Bitcoin ETFs (and a total of $125 billion in net assets across all such exchange-traded funds today) suggests to me that there's plenty of dry powder ready to flow into Bitcoin if this rally is sustained.

In this type of macro backdrop, with such volatile price swings from day to day, investors should be cautious. We'll have to see if this momentum can continue. However, for now, bulls appear to be stepping back into Bitcoin, setting up an interesting backdrop for the coming days and weeks.

Chainlink's cryptocurrency, LINK, is exhibiting early signs of recovery as it navigates a critical period of increased investor outflows. As of early December 2025, LINK's market activity has caught the attention of analysts due to a strategic demand zone that could potentially push its value past the $13 mark.

As of December 2025, Bitcoin has once again approached the $93,000 mark, a critical level that previously instigated a notable price drop. Recent analytics highlight the emergence of substantial short-liquidation clusters at this threshold, fueling speculation about an impending market squeeze.

XRP spot ETFs have posted one of the most consistent inflow streaks of this quarter, attracting roughly $756 million across eleven consecutive trading sessions since their Nov. 13 launch.

Yet the strength in the ETF demand contrasts with XRP’s price performance.

According to CryptoSlate’s data, the token has fallen about 20% over the same period and currently trades near $2.03.

Chart Showing XRP Price Performance in the Last 30 Days. (Source: TradingView)This divergence has prompted CryptoSlate to examine how XRP’s ownership structure is shifting beneath the surface.

The strong ETF inflows alongside falling prices point to a market absorbing two opposing forces of steady institutional allocation on one side and a broader risk reduction on the other.

Essentially, this pattern reflects a more complex process in which new, regulated demand is entering the ecosystem as existing holders adjust their exposure.

XRP dominates crypto ETFs flowThe inflow profile of XRP products is statistically remarkable, particularly against a backdrop of net redemptions elsewhere.

During the reporting period, Bitcoin ETFs saw over $2 billion in outflows, and Ethereum products recorded nearly $1 billion in withdrawals.

Even high-flying competitors like Solana have managed only about $200 million in cumulative inflows. At the same time, other altcoin ETFs have drawn smaller totals, with Dogecoin, Litecoin, and Hedera products each holding between $2 million and $10 million.

In this context, XRP stands alone for its consistent accumulation, with the four products now holding about 0.6% of the token’s total market capitalization.

XRP ETFs Daily Inflow (Source: SoSo Value)Considering this, market participants attribute the demand to the ETF’s operational efficiency. The four XRP funds offer institutional allocators a compliant, low-friction path into the asset, bypassing the custody headaches and exchange risks associated with direct token handling.

However, the fact that these inflows have not translated into upward price pressure suggests that other market segments may be reducing exposure or managing risk amid elevated macro and crypto-specific uncertainty.

This phenomenon is not unprecedented in crypto, but the scale here is distinct.

The selling pressure is likely originating from a combination of early adopters cashing out after years of volatility and potential treasury movements. The ETF boom has essentially created a liquidity bridge, allowing large-scale entities to offload positions without crashing the order book instantly.

Consolidation or centralization risk?Meanwhile, the ownership data below the surface reinforces the view that the asset is undergoing a radical centralization.

Data from blockchain analysis firm Santiment indicates that the number of “whale” and “shark” wallets holding at least 100 million XRP has plummeted by 20.6% over the past eight weeks.

XRP Holders (Source: Santiment)This pattern of fewer large wallets with more combined assets can be interpreted in different ways.

Some market observers have framed this as “consolidation,” arguing that supply is moving into “stronger hands.”

However, a risk-adjusted view suggests rising centralization risk.

With nearly half of the available supply concentrated in a shrinking cohort of entities, the market’s liquidity profile is becoming increasingly fragile.

This centralization of supply means that future price action is heavily dependent on the decisions of fewer than a few dozen entities. If this group decides to distribute, the resulting liquidity shock could be severe.

Simultaneously, spot exchange balances are thinning as tokens move into the regulated custody solutions required by ETF issuers.

While this theoretically reduces the “float” available for retail trading, it hasn’t triggered a supply shock. Instead, the transfer from exchange to custodian appears to be a one-way street for now, soaking up circulating supply sold by the shrinking whale cohort.

The benchmark raceThe inflow streak has renewed discussion about which asset could emerge as the benchmark altcoin for institutional portfolios.

Historically, regulated crypto exposure has centered almost exclusively on Bitcoin and Ethereum, with other assets attracting minimal attention. XRP’s recent flow profile, which has significantly exceeded the cumulative inflows of other altcoin ETFs, has temporarily shifted that dynamic.

Part of the interest stems from developments around Ripple. The firm’s licensing expansion in Singapore and the significant adoption of RLUSD, its dollar-backed stablecoin, give institutions a broader ecosystem to evaluate.

At the same time, Ripple’s acquisitions across custody, brokerage, and treasury management have created a vertically integrated framework that resembles components of traditional financial infrastructure, offering a foundation for regulated participation.

Still, analysts caution that a short inflow streak does not establish a new long-term benchmark.

XRP will need to sustain demand across multiple market phases to maintain its position relative to peers such as Solana, which has gained attention for its growing tokenization activity, and to assets that may attract larger flows once new ETFs launch.

For now, XRP’s performance within the ETF complex reflects early momentum rather than structural dominance.

The flows highlight genuine institutional interest, but the asset’s price behavior reflects the broader challenges large-cap cryptocurrencies face amid macroeconomic uncertainty.

Mentioned in this article

Journalist

Posted: December 3, 2025

XRP slipped below $2 after the 1st of December market crash and hit a local low near $1.90 before a mild rebound. At press time, Ripple’s [XRP] traded at $2.02, down 1.28% on daily charts and 8.42% on the weekly timeframe.

Even so, the broader weakness opened a buying window that whales quickly exploited.

Whales stayed active despite price weakness
Although XRP has struggled on its price charts, whales have remained increasingly active on the spot market. 

CryptoQuant data showed large values on the Spot Average Order Size metric for 30 straight days.

Source: CryptoQuant

When this metric shows whale orders, it indicates increased participation by them, either buying or selling the altcoin. 

In this case, these whales have been aggressively accumulating. This is so because the altcoin’s Spot Taker CVD has remained green for three consecutive weeks. 

Source: CryptoQuant

When this metric is green, it indicates buyer dominance, suggesting that most orders executed in the market are buy orders. 

XRP whale holdings hit a 7-year high
Interestingly, while whales remained active in the market, XRP has experienced a massive shift in holdings dynamics. 

According to Santiment, the number of 100M+ XRP wallets dropped 20.6% in eight weeks.

Having said that, the group’s total balance surged to 48 billion XRP, marking a seven-year high.

Source: Santiment

By contrast, Whale to Exchange Flow on Binance stayed minimal, hovering near 1k daily transfers for a month. That pattern showed whales avoided deposits and favored withdrawals, which aligned with an accumulation phase.

Source: CryptoQuant

Technical signals kept the market under bearish control
Significantly, prolonged XRP weakness on its price charts has created a buying window, especially for whales. Despite the increased whale demand, the altcoin remains structurally bearish.

For that reason, the altcoin’s Relative Vigor Index Zero Cross formed a bearish crossover, dropping to -0.02, indicating intense downward pressure.

Source: TradingView

With the crossover here, it suggests that bears are still increasingly active in the market, and whale demand remains inadequate for bulls to regain control.

These circumstances leave one in a risky position, potentially leading to greater losses. Therefore, if bearishness persists, XRP could breach $2 support again, with its Parabolic SAR at $1.9 providing support.

However, if whale demand finally materializes in the market, the altcoin could be strong enough to reclaim $2.2 and target $2.5.

Final Thoughts

The number of big wallets fell, but their total holdings climbed to a seven-year high, hinting at concentrated ownership.
Technical signals still leaned bearish, so XRP’s path depended on whether whale demand could offset pressure near $2.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

With the lack of direction of multiple assets, uncertainty covers the cryptocurrency market, which could be a worrying sign for investors: volatility might drop even lower and liquidity will be so thin that any selling pressure will send the market into limbo. 

XRP needs helpThere is very little space for optimism on the chart, and XRP is barely hanging onto the $2 level. The structure that has been building since early October, lower highs, lower lows and a clean descending channel are still fully intact. Every attempt to break above resistance has been slapped down immediately, and the most recent rejection from the midchannel region confirms sellers are still firmly in control.

The market is not confused. It is tired, illiquid and directionally biased to the downside. The way XRP is declining, rather than the drop itself, is the main problem. The price continues to retreat from the 20- and 50-day EMAs as if they were unbreakable barriers. Momentum never survives past a couple of candles, and volume on green days remains pathetic compared to the heavy sell-side spikes you see on each breakdown.

HOT Stories

XRP/USDT Chart by TradingViewThat is classic continuation behavior — not a base, not an accumulation zone, not even a meaningful pause. Losing $2 logically opens the door to the next liquidity pocket around $1.85-$1.90, and if the channel breaks again (like it did during the panic wick in November), you are talking about an even deeper slide.

Nothing on the chart hints at incoming strength. The RSI is hovering around mid-40s, but without a divergence or a trend shift, that is just neutral noise. The 200-day EMA sits far above the current price, and the 50/100 EMA mini-death cross continues to pressure the asset from above.

The problem is that XRP typically bottoms out. Historically, its reversals come from overextended capitulation rather than controlled selling. But right now, we do not even have that exhaustion. 

So yes, the next leg lower is not just possible, it is the most coherent outcome based on structure and momentum. Furthermore, nothing indicates that things will get better unless XRP produces a truly unusual spike in demand. Buyers are not stepping in, and the chart reflects that brutally.

Bitcoin can recoverBitcoin’s current structure is messy but not hopeless. The price eventually found buyers in the mid $80,000s after the violent plunge in mid November, and a clear recovery was initiated. The recovery is sufficient to pave the way for a brief move toward $90,000, but it is not strong enough to signal a trend reversal.

The key is the shape of the bounce. BTC printed a classic exhaustion wick near the local bottom, followed by a string of higher lows on increasing volume. That alone signals buyers are not dead. But the real driver is the gap between spot price and the 20-day EMA.

You Might Also Like

Another structural factor is that, in November, an extremely oversold RSI reading was created, which Bitcoin typically resolves with a relief rally. The price recovered enough to test significant resistance the last time the momentum reset this dramatically. The same dynamic is possible now.

The problem is that the chart above $90,000 is stacked with resistance. The $92,000 to $96,000 pocket is where the 50- day EMA, the prior breakdown zone and the cluster of unsuccessful support levels from October converge. Unless there is a shift in macro sentiment or an increase in demand, that area is a brick wall.

So yes, hitting $90,000 is not a stretch. It fits the pattern: oversold bounce returning to test the underside of broken support. But expecting anything beyond that, especially a sustained breakout, does not match the current market posture. BTC is still firmly below the 200 day EMA, still printing lower highs and still lacking the kind of buying aggression that defines trend shifts.

Dogecoin's stabilization risksDogecoin is trying to stabilize, but calling this the end of the downtrend would be wishful thinking. The chart is still locked inside a clean, well-defined descending structure, with every bounce getting sold almost immediately. The latest move, a push off the $0.13 to $0.14 zone, is more of a technical relief than an actual shift in market sentiment.

The price remains below the 20-day, 50-day and 200-day EMAs. The three are stacked in a classic bearish pattern, all pointing downward. That alignment rarely resolves quickly, and it tells you that traders still have control.

The key level to watch is $0.155 to $0.16. This is where DOGE was repeatedly slapped down, and the midpoint resistance of the most recent slide. If buyers cannot reclaim that zone, any discussion about a trend reversal is pointless. Breaking it would at least show that sellers are losing their grip, and not starting a bullish trend but making the first step toward one.

You Might Also Like

However, Bitcoin is the more significant external factor. DOGE does not get to move independently in market conditions like these. BTC is still deep inside its own downtrend, and every failed bounce there cascades straight into assets like DOGE. Meme assets remain suppressed if Bitcoin keeps declining, or even just chopping sideways in the face of significant resistance.

So, is the DOGE downtrend ending? Nothing on the chart confirms that. Investors should expect more sideways-to-down behavior unless BTC prints a real recovery leg. Without broader market strength, DOGE is likely to keep drifting, and any short-term bounces will remain just that, bounces not reversals. Liquidity drains fast, and speculative appetite evaporates, exactly the environment DOGE performs the worst in.

flash news

Crypto market surges past $3 T as ETF demand feeds rebound

The global crypto market gained over $200 billion today as major digital assets rebounded sharply. The surge follows renewed institutional interest and a wave of ETF

CryptoCurrency News

Crypto Markets Bounce Back: BTC, ETH, XRP Spike Following Heavy Liquidations

TL;DR: BTC jumps past $90K, triggering $312M in crypto derivative liquidations. ETH rises above $3,000 ahead of Fusaka upgrade, XRP surges 7.3% to $2.14. ETFs

flash news

American Bitcoin Stock Sheds 50% Amid Breakdown in BTC Proxy Dynamics

American Bitcoin Corp (ABTC) fell more than 50% in Tuesday’s opening session, hitting an intraday low of $1.75, as the crypto market correction pressured Bitcoin-linked

flash news

Bitcoin Outlook: Grayscale Predicts 2026 Highs, Challenges Halving Cycle Narrative

Bitcoin could reach new highs in 2026, according to Grayscale, which dismisses the four-year cycle theory. The firm notes that pullbacks of 25% or more

Technology

Ethereum’s Mainnet Upgrade Hits Tomorrow: What ETH’s ‘Sloping Side Road’ Means for You

TL;DR Ethereum will activate the Fusaka upgrade tomorrow, which increases rollup capacity, doubles the block gas limit, and adds native support for passkey-style signatures. PeerDAS

Companies

Kraken Acquires Backed Finance to Expand Its Tokenization Strategy

TL;DR Kraken is acquiring Backed Finance and bringing issuance, trading, and settlement of tokenized stocks and ETFs directly into its global infrastructure. The integration builds

As of December 2025, Strategy, a prominent player in the cryptocurrency sector, is projected to experience a remarkable 183% growth in its stock value despite ongoing market pressures related to Bitcoin (BTC). This potential growth trajectory is capturing significant attention within financial circles, particularly as it contrasts sharply with the broader market sentiment of uncertainty surrounding Bitcoin.

In a significant shift within the cryptocurrency landscape, the number of wallets holding over 100 million XRP tokens has decreased sharply, according to data from Santiment, a leading crypto analytics firm. Over the past eight weeks, these substantial XRP wallets have diminished by 20.6%, marking a reduction of 569 wallets in this category.

In brief
Digital assets rallied on Tuesday after falling significantly a day earlier.
Last week, 30% of Myriad users expected a crypto winter.
Bitcoin is down about 27% since hitting an all-time high above $126,000 in early October.
As Winter Storm Chan barrels down on New York, Myriad prediction market traders are issuing a more favorable forecast for crypto prices.

Users on Myriad, which is owned by Decrypt parent company Dastan, rate a 9% chance that markets are headed for crypto winter. That’s dropped from 30% since the market debuted on Friday at the end of a week in which Bitcoin hovered around $85,000 much of the time–not far off its six-month lows.

The improvement dovetails with rebound in crypto prices on Tuesday after a more than six-week slump. BTC was trading above $91,500, up 6% over the past 24 hours, although BTC remains about 27% lower than its all-time high above $126,000 set in early October, according to crypto price aggregator CoinGecko.

Ethereum was trading for $2,990 at the time of writing, a 7.3% gain since Monday, same time. On Wednesday, the Ethereum developer community rolls out the Fusaka upgrade, which will dramatically change how the mainnet collects and verifies data from layer-2 networks. ETH is off more than 20% over the past month.

For the purposes of the prediction market, three out of the following four criteria would need to be met to qualify as a Crypto Winter: Bitcoin drops to $35,000; Ethereum drops to $1,000; MicroStrategy, or MSTR, falls to $50; or the Crypto total market capitalization on TradingView would need to drop to $350 billion.

More generally, a crypto winter describes an extended market downturn when prices drop, trading activity slows, and investor interest cools for months or even years.

The most recent crypto winter ran from late 2021 through most of 2023, triggered by the bursting of the pandemic-era bull market and worsened by the collapses of Terra/Luna in 2022, and the resulting contagion that triggered the failure of crypto hedge fund Three Arrows Capital in June and crypto exchange FTX in November that same year.

During that period, Bitcoin fell from an all-time high near $69,000 in November 2021 to about $16,000 after FTX’s failure—a drawdown of roughly 75%. Venture funding and trading volumes dropped dramatically, too.

But even if crypto winter isn’t on the horizon, Bitcoin and Ethereum have incurred recent price weakness.

Analysts at QCP Capital, a Singapore-based crypto trading firm, pegged Monday’s dip to hawkish sentiment from Bank of Japan Governor Kazuo Ueda.

As a result, “Japan’s two-year yield to 1% and [implies] a 76% chance of a rate increase at the 19 December BOJ meeting,” the analysts wrote. Traders are also keeping an eye on the U.S. Federal Open Markets Committee as it heads into its last meeting for the year.

Analysts told Decrypt that the U.S. central bank’s interest rate decision next week will be a huge determining factor in how Bitcoin ends the year.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.